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Introduction: Scleroderma is a chronic inﬂammatory, autoimmune disease that is
characterized by generalized ﬁbrosis of skin and visceral organs. Although interstitial
pulmonary ﬁbrosis is the most common pulmonary manifestation, pulmonary
hypertension due to pulmonary vasculopathy is also seen frequently. Despite new
developments in treatment options, pulmonary hypertension accompanying connec-
tive tissue disease such as scleroderma has a poor prognosis. The objective of this
study was to determine mortality in scleroderma patients with pulmonary hypertension
as well as the predictors of mortality.
Materials-Methods: 21 scleroderma patients with pulmonary hypertension were
included in this study. The patients had a detail history, physical examination and
electrocardiography performed and pulmonary hypertension was diagnosed by
transthoracic echocardiography along with right heart catheterization during which
systolic, diastolic and mean pulmonary artery pressures were measured. High reso-
lution tomography was used to diagnose interstitial pulmonary disease and inﬂam-
matory markers and autoantibodies were also measured. 6 minute walking test was
used to evaluate functional capacity during diagnosis and evaluation of pulmonary
capacity was performed by pulmonary function testing and diffusion capacity
measurements. All patients were followed with hospital visits and mortality was
determined from hospital records.
Results: Patients included in the study were predominantly females (16 females, 5
males); the mean age was 57.9 years (38 - 82) and mean follow-up period was
9.66.8 years. 7 (33%) patients died during follow-up. The demographic and imaging
test characteristics are shown in Table 1 and the results of catheterization and 6 minute
walking test are shown in Table 2. In single variable analysis, distant organ
involvement and presence of digital ulcer, low body mass index, degree of tricuspid
regurgitation and systolic pulmonary pressure in echocardiography, and CRP level
were found to be signiﬁcant as predictors of mortality. In multiple variable analysis,
presence of digital ulcer and CRP level were found to be signiﬁcant as predictors
of mortality in scleroderma patients with pulmonary hypertension.
Discussion: Pulmonary hypertension accompanying scleroderma seriously decreases
the survival of these patients. Determination of high risk patients is important for
intensiﬁcation of treatment strategies and early intervention. In this study, approxi-
mately one-thirds of the patients died in about 10 years of follow-up. This study sheds
light on the possible predictors of mortality of these patients and these predictors can
be used for the early determination of high risk patients.Table 1
Age (years) 57,9  12,0
Sex (female) 16
Body mass index (kg/m2) 27,1  4,3
End diastolic diameter (cm) 4,4  0,3
End systolic diameter (cm) 2,8  0,4
Ejection fraction (%) 65,5  7,2
Diastolic right ventricular diameter (cm) 2,9  0,5
Pulmonary arterial pressure (mmHg) 65,0  34,0
Diffusion capacity (%) 45,6  13,0
Pulmonary artery diameter on CT 34,8  3,2
Baseline demographic and imaging characteristics
Table 2
6 min walking distance (meter) 262,4  96,1
Before 6 min walking dyspnea score (1-10) 3,4  2,5
After 6 min walking dyspnea score (1-10) 4,6  2,2
Right atrial pressure (mmHg) 11,0  5,3
Right ventricular systolic pressure (mmHg) 64,7  22,6
Right ventricular diastolic pressure (mmHg) 11,8  5,9
Systolic pulmonary arterial pressure (mmHg) 65,5  23,3
Mean pulmonary arterial pressure (mmHg) 43,9  13,4
Diastolic pulmonary arterial pressure (mmHg) 28,5  9,9
Pulmonary capillary wedge pressure (mmHg) 13,2  3,6
Cardiac output (L/min) 5,6  0,7
Results of 6 minute walking test and right heart catheterization
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Introduction: Recent studies have demonstrated the potential role of microRNAs
(miRNA) as biomarkers in various cardiovascular disorders. Left ventricle hyper-
trophy and dilatation are among changes encountered in the remodeling process in
patients with congestive heart failure (CHF).
The aim of this study was to investigate the relationship between expression levels
of dysregulated miRNAs and echocardiographic parameters related with left
ventricular mass index in chronic CHF patients.
Methods: In our study, 20 clinically stable (NYHA II) and 22 decompensated (NYHA
III and IV) systolic CHF (ejection fraction (EF) <%40) cases were enrolled. Whole
genome miRNA proﬁling was done with microarray method and dysregulated miR-
NAs were detected compared to 15 healthy controls. All patients underwent trans-
thoracic echocardiography in order to determine left ventricular EF, dimensions, left
ventricular mass index (LVMI) and tissue doppler peak systolic velocity of mitral
annulus values.
Results: A total of 29 miRNAs were up or down regulated in CHF patients. Out of
these 29 miRNAs, ﬁve were demonstrated to be correlated with LVMI values.
Speciﬁcally, miR-182 (p¼0.04), miR-200a-star (p¼0.019), and miR-568 (p¼0.023)
were found to be negatively correlated with LVMI. On the other hand, mir-155
(p¼0.019), and miR-595 (p¼0.04) were positively correlated with LVMI in patients
with CHF. There was no relation between expression levels of dysregulated miRNAs
and following echocardiographic parameters: EF (p>0.05) and tissue doppler peak
systolic velocity of mitral annulus (p>0.05).
Conclusion: This study demonstrates the signiﬁcant relationship between some, but
not all of the dysregulated miRNAs and left ventricular mass index values in systolic
CHF patients.
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Introduction: MicroRNAs (miRNAs) are small, endogenous and non-coding RNAs
that are 21-25 nucleotides in length. Recent studies have demonstrated the role of
miRNAs as potential biomarkers in various disorders. The aim of this study was to
investigate the diagnostic importance of miRNAs in congestive heart failure (CHF).
Methods: In our study, 20 clinically stable (NYHA II) and 22 decompansated (NYHA
III and IV) systolic CHF (EF<%40) patients and 15 healthy controls were enrolled.
Whole genome miRNA proﬁling was done and dysregulated miRNAs were detected
with microarray method in CHF patients compared to healthy controls. Also, the
serum levels of pro-Brain Natriuretic Peptide (BNP), high sensitive C-reactive protein
(hs-CRP) and uric acid were measured.
Results: Microarray proﬁling showed serum miR-21, miR-4278, miR-650, miR-
744star, miR-516-5p, miR-1292, miR-182, miR-1228, miR-595, miR-663b, miR-
1296, miR-1825, miR-299-3p, miR-662 miR-122-star, miR-3148, miR-518e-star,
miR-2054 as up regulated, and serum miR-129-3p, miR-3155, miR-3175, miR-583,
miR-568, miR-30d, miR-200a-star, miR-1979, miR-371-3p, miR-155-star, miR-502-
5p as down regulated in CHF.
The diagnostic values of miR-4278 (AUC 1.00 p<0.0001), miR-516-a-5p (AUC
1.00 p<0.0001) and miR-1228 (AUC 1.00 p<0.0001) were found to be very high
compared to other known important clinical prognostic markers as pro-BNP (AUCLS C17
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S0.98 p<0.0001), hs-CRP (AUC 0.958 p<0.0001) and uric acid (AUC 0.97 p<0.0001)
with ROC curve analysis in patients with CHF (Figure).
Conclusion: We identiﬁed 29 miRNAs that were elevated in patients with CHF,
among which miR-4278, miR-516-a-5p and miR-1228 were most signiﬁcant in terms
of clinical diagnosis. This study demonstrates the value of miR-4278, miR-516-a-5p,
miR-1228 as potential diagnostic biomarkers in CHF.OP-044
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Purpose: Heart Failure (HF) is a fatal disease. Several biomarkers are of interest with
regard to prognosis. However, plasma osmolality which unites the individual inﬂu-
ences of sodium, BUN and glucose has not been studied.
Methods: 496 patients with HF out of two participating centers were investigated as
part of a larger cohort and followed up to 111 months. Plasma osmolality was
calculated as "(2*Na)+(BUN/2.8)+(Glucose/18)". When ROC curve was obtained, it
was noticed that the curve is sigmoid shaped. Hence three subcategories were iden-
tiﬁed. Patients were classiﬁed into three groups as follows: Those with plasma
osmolality<287 mOsm/kg (hypoosmolality), those with osmolality between 287-295
(normoosmolality, blue line in ﬁgure), and those with plasma osmolality>295 mOsm/
kg (hyperosmolality).
Results: Mean EF of the cohort was 2710% with a mean age of 55.917.8 years
(369 males, 127 females) Patients were followed up for 2723 months and mortality
was noted. Kaplan Meier curves for three subcategories of plasma osmolality sepa-
rated from each other (p¼0.0296, Figure 1). After follow up, 42.6% of those with low
osmolality, 34.7% of those with high osmolality versus 22.8% of those with
normoosmolality died (p¼0.0003). It was also noted that up to 40 months of follow
up, those with hypoosmolality (red line) had the worst prognosis, then, there was
a switch between hypo and hyperosmolality groups with the hyperosmolality group
(yellow line) having the worst prognosis thereafter.
Conclusion: Plasma osmolality predicts both mid term and long term mortality of
patients.C18 JACC VOP-045
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Aim: Although it was shown that increased basal red cell distribution width (RDW)
level is an index of hospitalization and mortality of patient with heart failure (HF),
the relationship between RDW and risk of stroke has not been investigated
comprehensively Therefore, in this particular study, we aimed to investigate the
association between baseline RDW level and the risk of stroke in heart failure patients.
Methods: One hundred-ﬁfty three consecutive HF patients [NYHA I–III and left
ventricular ejection fraction (LVEF) of <40%] were included in this prospective
study. All patients were followed up for one year and during this period cerebro-
vascular disease was questioned.
Results: In matched population, using propensity score matching, HF patients
suffering from stroke compared with patients without stroke we found signiﬁcantly
increased basal RDW and serum uric acid. The ROC curves of RDW for predicting
stroke is shown that RDW 15.2% measured on admission had 87% sensitivity and
74% speciﬁcity in predicting stroke in patients with heart failure (AUC:0.923, 95%
CI: 0.852-0.994, p<0.001).
Conclusion: In this study, for the ﬁrst time in literature, we evaluated the relationship
between baseline RDW levels and the risk of stroke in heart failure patients. The study
results revealed that elevated basal levels of RDW in stable heart failure patients are
signiﬁcantly associated with stroke, according to propensity score analysis.
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Purpose: The purpose of investigation to study relation to levels of erythropoietin and
pathological cytokine of patients in chronic heart failure with anaemic syndrome and
erythropoietinic effect and security of continuous erythropoietin receptor activator
methoxy polyethilenglicol-epoietin beta (MEB) its impact on this relation and on
regress of symptoms chronic heart failure.
Methods: 94 patients with chronic heart failure of New York Heart Association
(NYHA) class ___-_V a left ventricular ejection fraction of 40% or less with anaemia
were included in investigation. Mean age of patients 59,71,6 years (58 males,
36 females). A hemoglobin level of less 120 g/l by males and less 110g/l by females.
46 patients were treated basis treatment of CHF (_ group) and 48 patients were
treated with MEB (__ group). Percutaneous MEB in dose 50 IU in day in one months
patients without iron deﬁciency to receive in follow-up on 6 months. Echocardio-
graphic indices of LV systolic and diastolic function, plasma NT pro BNP, cytocine,
erythropoietin, ferritin and 6 minute walked distance were assessed at baseline and
posttreatment.
Results: On the patients CHF with anemic syndrome in __ group MEB treatment the
level Hb increased on 22,4% (p<0,05) and erythropoietin levels in serum plasma
increased to 29,34,3 IU/ml (p<0,001).The increase the level of erythropoietin
connected with the decrease of level pathological cytokines: Il-1on 36,6% (p<0,001),
Il-6 on 54,3% (p<0,05),TNF-a on 48,3% (p<0,05) compared with of patients
receiving _ group. MEB treatment had a signiﬁcantly increase LVEF on 19,04%
(p<0,05) as compared with of patients receiving _ group.A greater 6-minute distance
walked on exercise testing increased on 76,6% (p<0,05) after treatment MEB.There
was also a signiﬁcant fall in serum NT pro BNP levels from 387,452,3 fmol/ml to
198,130,3 fmol/ml (p<0,01).
Conclusion: On the patients of CHF with anemic syndrome erythropoietin failure
increase sytokincal aggression with worsens clinical picture of the illness. Correction
of anemic syndrome with application of percutaneus ME B in dose 50 IU in day in one
month in follow-up 6 months effective to improve erythropoietin failure and cytokinic
aggression connected to it and anemia; clinical symptoms and quality of life in
anaemic CHF patients.ol 62/18/Suppl C j October 26 29, 2013 j TSC Abstracts/ORALS
